NCT06872060View on ClinicalTrials.gov

The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance.

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 1, 2026

Primary Completion Date

November 1, 2027

Study Completion Date

November 1, 2027

Conditions
Kidney Diseases
Interventions
DRUG

Glucagon

Glucagon infusion at 5 ng·kg-¹·min-¹ from 0-30 minutes and 10 ng·kg-¹·min-¹ from 30-60 minutes.

DRUG

Glucagon+Exendin9-39

Glucagon infusion at 5 ng·kg-¹·min-¹ from 0-30 minutes and 10 ng·kg-¹·min-¹ from 30-60 minutes, plus a GLP-1R antagonist, exendin 9-39 (900 pmol·kg-¹·min-¹), given intravenously from -30 to 60 minutes

DRUG

Sodium chloride

Placebo (0.9% NaCl).

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER